H&T Presspart, the world’s leading manufacturer of components for metered dose inhalers (MDIs), are pleased to announce they will be presenting at this year’s Inhalation Asia conference in Macau, China, which runs from the 13-15 September.

The presentation entitled ‘Smart Inhalers- Device Design & Technology’ will be given delivered by Dana Shears, H&T Presspart’s Director of Future Market Development, on Friday 15th September at 11.30am.

The speech at this year’s conference follows on from the launch at last year’s DDL exhibition of H&T Presspart’s eMDI smart connected inhaler. The eMDI is the first market-ready, fully-embedded, intuitive, connected inhaler which can be used in conjunction with a healthcare app to track adherence and usage.

A number of key areas will be covered by Mr Shears in his speech including:

  • Global health data confirms that poor patient adherence to long-term therapies, such as asthma and COPD, contribute significantly to rising healthcare cost.
  • Smart Inhalers are emerging which enables more effective monitoring of patient compliance and adherence
  • Key Considerations in the design of H&T Presspart’s eMDI
  • Smart inhalers face numerous challenges, from a wide range of stakeholders, for successful adoption on a global scale
H&T Presspart’s PowdAir Plus capsule based dry powder inhaler (DPI)


As well as the presentation on Smart Inhalers, you will also be able to find H&T Presspart in the exhibition hall at table 17. Here, you can find out all the latest on H&T Presspart’s other products and services including the recently launched PowdAir Plus– a new capsule based dry powder Inhaler.

Inhalation Asia, which is now in its third year, is a non-commercial conference that aims to provide an opportunity for people who work on pulmonary and intranasal drug delivery in Asia to network and showcase their research, products and services. For a full programme of the 3 day event please visit the Inhalation Asia website (add link).